| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
|
J Natl Cancer Inst
|
2006
|
10.06
|
|
2
|
Effects of radiation on normal tissue: consequences and mechanisms.
|
Lancet Oncol
|
2003
|
3.70
|
|
3
|
Animal models for medical countermeasures to radiation exposure.
|
Radiat Res
|
2010
|
2.83
|
|
4
|
Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003.
|
Radiat Res
|
2004
|
2.33
|
|
5
|
Combining radiotherapy and immunotherapy: a revived partnership.
|
Int J Radiat Oncol Biol Phys
|
2005
|
2.29
|
|
6
|
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma.
|
Clin Cancer Res
|
2003
|
1.83
|
|
7
|
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer.
|
J Clin Oncol
|
2009
|
1.82
|
|
8
|
Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited.
|
Stem Cells
|
2010
|
1.78
|
|
9
|
The biological effectiveness of antiproton irradiation.
|
Radiother Oncol
|
2006
|
1.66
|
|
10
|
T-cell responses to survivin in cancer patients undergoing radiation therapy.
|
Clin Cancer Res
|
2008
|
1.61
|
|
11
|
Maximizing tumor immunity with fractionated radiation.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.60
|
|
12
|
The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
|
Clin Cancer Res
|
2006
|
1.51
|
|
13
|
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
|
Clin Cancer Res
|
2006
|
1.48
|
|
14
|
Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.
|
Cancer Res
|
2006
|
1.45
|
|
15
|
Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells.
|
J Immunol
|
2004
|
1.44
|
|
16
|
National Institutes of Health funding in radiation oncology: a snapshot.
|
Int J Radiat Oncol Biol Phys
|
2013
|
1.42
|
|
17
|
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy.
|
J Immunother
|
2004
|
1.40
|
|
18
|
Molecular mechanisms of late normal tissue injury.
|
Semin Radiat Oncol
|
2007
|
1.40
|
|
19
|
Radiation enhances regulatory T cell representation.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.39
|
|
20
|
Ionizing radiation activates the Nrf2 antioxidant response.
|
Cancer Res
|
2010
|
1.35
|
|
21
|
The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
|
Cancer Res
|
2002
|
1.31
|
|
22
|
Effects of recombinant erythropoietin on breast cancer-initiating cells.
|
Neoplasia
|
2007
|
1.29
|
|
23
|
Cytokines in radiobiological responses: a review.
|
Radiat Res
|
2012
|
1.29
|
|
24
|
Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.28
|
|
25
|
After the bomb drops: a new look at radiation-induced multiple organ dysfunction syndrome (MODS).
|
Int J Radiat Biol
|
2011
|
1.24
|
|
26
|
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
|
Clin Cancer Res
|
2003
|
1.24
|
|
27
|
Links between innate immunity and normal tissue radiobiology.
|
Radiat Res
|
2010
|
1.19
|
|
28
|
Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors.
|
Clin Cancer Res
|
2009
|
1.19
|
|
29
|
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.12
|
|
30
|
Compartmental responses after thoracic irradiation of mice: strain differences.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.11
|
|
31
|
Radiation responses of cancer stem cells.
|
J Cell Biochem
|
2009
|
1.08
|
|
32
|
Anthracyclines, proteasome activity and multi-drug-resistance.
|
BMC Cancer
|
2005
|
1.08
|
|
33
|
The confluence of stereotactic ablative radiotherapy and tumor immunology.
|
Clin Dev Immunol
|
2011
|
1.05
|
|
34
|
Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses.
|
J Immunother
|
2004
|
1.03
|
|
35
|
Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus.
|
Antivir Ther
|
2005
|
1.02
|
|
36
|
High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones.
|
Clin Cancer Res
|
2009
|
1.02
|
|
37
|
N-acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-kappaB activation.
|
Free Radic Biol Med
|
2002
|
1.01
|
|
38
|
Bronchoalveolar lavage and interstitial cells have different roles in radiation-induced lung injury.
|
Int J Radiat Biol
|
2003
|
1.00
|
|
39
|
SOCS3 regulates p21 expression and cell cycle arrest in response to DNA damage.
|
Cell Signal
|
2008
|
0.98
|
|
40
|
Regulatory T cells in radiotherapeutic responses.
|
Front Oncol
|
2012
|
0.98
|
|
41
|
The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism.
|
BMC Cancer
|
2005
|
0.97
|
|
42
|
Preparing for the future of radiation oncology.
|
J Am Coll Radiol
|
2007
|
0.97
|
|
43
|
Spinal cord tolerance to single-fraction partial-volume irradiation: a swine model.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.96
|
|
44
|
Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells.
|
Cancer Res
|
2005
|
0.96
|
|
45
|
Functional phenotype of macrophages depends on assay procedures.
|
Int Immunol
|
2007
|
0.95
|
|
46
|
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade).
|
J Immunol
|
2006
|
0.95
|
|
47
|
Lymphatic fistulas: obliteration by low-dose radiotherapy.
|
Strahlenther Onkol
|
2005
|
0.94
|
|
48
|
Radioprotective effects of Bmi-1 involve epigenetic silencing of oxidase genes and enhanced DNA repair in normal human keratinocytes.
|
J Invest Dermatol
|
2011
|
0.93
|
|
49
|
Induction of radioprotective peroxiredoxin-I by ionizing irradiation.
|
J Neurosci Res
|
2002
|
0.92
|
|
50
|
The effects of tea extracts on proinflammatory signaling.
|
BMC Med
|
2006
|
0.91
|
|
51
|
HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway.
|
Cancer Res
|
2006
|
0.91
|
|
52
|
Protection against radiation-induced bone marrow and intestinal injuries by Cordyceps sinensis, a Chinese herbal medicine.
|
Radiat Res
|
2006
|
0.91
|
|
53
|
Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells.
|
J Immunol
|
2004
|
0.91
|
|
54
|
High throughput screening of small molecule libraries for modifiers of radiation responses.
|
Int J Radiat Biol
|
2011
|
0.90
|
|
55
|
Spinal cord tolerance to reirradiation with single-fraction radiosurgery: a swine model.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.89
|
|
56
|
Differential Effects of the Proteasome Inhibitor NPI-0052 against Glioma Cells.
|
Transl Oncol
|
2010
|
0.88
|
|
57
|
Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation.
|
Mol Cancer Res
|
2008
|
0.87
|
|
58
|
5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.87
|
|
59
|
Modification of the tumor microenvironment to enhance immunity.
|
Front Biosci
|
2007
|
0.86
|
|
60
|
T lymphocytes and normal tissue responses to radiation.
|
Front Oncol
|
2012
|
0.86
|
|
61
|
Education and training for radiation scientists: radiation research program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12-14, 2003.
|
Radiat Res
|
2003
|
0.86
|
|
62
|
Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells.
|
Cancer Gene Ther
|
2005
|
0.86
|
|
63
|
Proteasome structures affected by ionizing radiation.
|
Mol Cancer Res
|
2005
|
0.86
|
|
64
|
Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
|
Head Neck
|
2005
|
0.86
|
|
65
|
Fibrin microbeads loaded with mesenchymal cells support their long-term survival while sealed at room temperature.
|
Tissue Eng Part C Methods
|
2011
|
0.86
|
|
66
|
Integration of epidermal growth factor receptor inhibitors with preoperative chemoradiation.
|
Clin Cancer Res
|
2010
|
0.84
|
|
67
|
Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models.
|
J Immunother
|
2013
|
0.84
|
|
68
|
Marrow-derived stromal cell delivery on fibrin microbeads can correct radiation-induced wound-healing deficits.
|
J Invest Dermatol
|
2012
|
0.84
|
|
69
|
Counteracting tumor radioresistance by targeting DNA repair.
|
Mol Cancer Ther
|
2005
|
0.83
|
|
70
|
Adenoviral interleukin-3 gene-radiation therapy for prostate cancer in mouse model.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.83
|
|
71
|
Local irradiation of murine melanoma affects the development of tumour-specific immunity.
|
Immunology
|
2009
|
0.83
|
|
72
|
Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland, September 6-8, 2000.
|
Radiat Res
|
2002
|
0.83
|
|
73
|
Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
|
Prostate
|
2003
|
0.82
|
|
74
|
Spinal cord tolerance to single-session uniform irradiation in pigs: implications for a dose-volume effect.
|
Radiother Oncol
|
2012
|
0.82
|
|
75
|
Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study.
|
Int J Colorectal Dis
|
2008
|
0.81
|
|
76
|
Modifying radiation damage.
|
Curr Drug Targets
|
2010
|
0.81
|
|
77
|
Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines.
|
Cancer Gene Ther
|
2002
|
0.81
|
|
78
|
The proteasome inhibitor MG-132 protects hypoxic SiHa cervical carcinoma cells after cyclic hypoxia/reoxygenation from ionizing radiation.
|
Neoplasia
|
2006
|
0.81
|
|
79
|
Cordyceps sinensis health supplement enhances recovery from taxol-induced leukopenia.
|
Exp Biol Med (Maywood)
|
2008
|
0.81
|
|
80
|
Double blind randomized phase II study with radiation+5-fluorouracil+/-celecoxib for resectable rectal cancer.
|
Radiother Oncol
|
2009
|
0.80
|
|
81
|
Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.80
|
|
82
|
Imaging of radiation effects on cellular 26S proteasome function in situ.
|
Int J Radiat Biol
|
2009
|
0.79
|
|
83
|
Radiation biology in the context of changing patterns of radiotherapy.
|
Radiat Res
|
2014
|
0.79
|
|
84
|
A novel modular polymer platform for the treatment of head and neck squamous cell carcinoma in an animal model.
|
Arch Otolaryngol Head Neck Surg
|
2012
|
0.77
|
|
85
|
Survival of AIDS patients with primary central nervous system lymphoma may be improved by the radiosensitizing effects of highly active antiretroviral therapy.
|
AIDS
|
2002
|
0.76
|
|
86
|
Broad antitumor protection by dendritic cells administered to CD8alpha knock out mice.
|
Cancer Immunol Immunother
|
2005
|
0.75
|
|
87
|
Immune rejection in a humanized model of murine prostate cancer.
|
Anticancer Res
|
2010
|
0.75
|